
Bharath T. PhD
401 posts

Bharath T. PhD
@PreemptDisease
Founder & CEO https://t.co/ul0mf5Jqsk #DeepTech #DARPA & NIH funded. Builds complex nano-bio-ML products, towards disease preemption. Improv practiced in empty rooms.


Most podcasts are BS because they are fluffy and lack substance. This is the densest, most insightful episode you will listen to this year. @gokulr breaks down the 8 defensible moats you need for your company to be successful in a world of AI. 1. Data (Proprietary and inaccessible) 2. Workflow (Deeply embedded operations) 3. Regulatory (Licenses and contracts) 4. Distribution (Exclusive proprietary channels) 5. Ecosystem (Third-party platform reliance) 6. Network (Marketplace liquidity density) 7. Physical (Infrastructure and atoms) 8. Scale (Low cost through volume) (Links below)




Excited to launch the @Ginkgo Cloud Lab service today! Recently, GPT-5 ordered experiments from Ginkgo's autonomous lab in our work with @OpenAI below -- now we're making our lab available to users (or their AI models) in the cloud to order lab experiments and get back data online. Play around with it now! You can ask our agent about your protocol and it will do its best to evaluate if we can run it and what it would cost. cloud.ginkgo.bio/protocols To start we've launched 3 Ginkgo Certified Protocols, two around cell free protein expression and one to make bacterial pixel art 😀 We will be adding new protocols weekly -- at first ones we certify, but eventually users will order whatever experiment they want as long as we have the needed equipment on our autonomous lab! We hope that Cloud Labs will someday allow anyone to be a scientist with their own lab just like personal computers and cloud data centers democratized programming and the web. More in thread 🧵and happy to answers Qs if you post!





2/ Q4 2025 Lux LP Letter…




Introducing M2.5, an open-source frontier model designed for real-world productivity. - SOTA performance at coding (SWE-Bench Verified 80.2%), search (BrowseComp 76.3%), agentic tool-calling (BFCL 76.8%) & office work. - Optimized for efficient execution, 37% faster at complex tasks. - At $1 per hour with 100 tps, infinite scaling of long-horizon agents now economically possible MiniMax Agent: agent.minimax.io API: platform.minimax.io CodingPlan: platform.minimax.io/subscribe/codi…

GPT-5.2 derived a new result in theoretical physics. We’re releasing the result in a preprint with researchers from @the_IAS, @VanderbiltU, @Cambridge_Uni, and @Harvard. It shows that a gluon interaction many physicists expected would not occur can arise under specific conditions. openai.com/index/new-resu…



First proof-of-concept for engineered T cells as a potential treatment for Alzheimer's disease @jonykipnis @boskovic_p @PNASNews @justsaysinmice pnas.org/doi/10.1073/pn…

The Iso team has cooked something incredible: our new technical report unveils the latest results from our drug design engine, the IsoDDE, progressing far beyond AlphaFold 3. This breaks new ground compared to AF and other similar methods by a significant degree across all key benchmarks. 1/7


Heuristics for lab robotics, and where its future may go (8.4k words, 38 minutes reading time) owlposting.com/p/heuristics-f… this is the longest article i have ever written. in it, i discuss the three ideologies of lab robotics progress, why they may all converge on the same business model, whether any of it will be actually helpful for the problems that plague drug discovery the most, and more this article involved discussions with sixteen people over the course of three weeks, and i am very grateful to them for answering the many questions i had about a field that i had long considered alien finally: this is a complicated field that is really still being birthed, so please let me know if i got anything wrong


